Last month, the Connecticut legislature ended its 2019 consultation with a package deal of bills geared toward decreasing deadly overdoses and drug-related harm within the nation. One superb step is the inclusion of $8 million in funding with the aid of Gov. Ned Lamont inside the nation’s finances to grow the status quo of medicine-based total treatment for opioid use sickness in correctional settings. But plenty of what exceeded changed into reactionary to the overdose crisis rather than a proactive technique primarily based on what became found out from the failed drug struggle.
Act Increasing Criminal Penalties for the Sale of Fentanyl, passed via the legislature and signed with the aid of Gov. Lamont, increases consequences for promoting fentanyl. On the hassle of fentanyl, the legislature chose a conventional drug warfare method: criminalization. History, research, and common feeling have proven that arresting and incarcerating individuals who use and deal with pills is ineffective in decreasing drug use or drug-related crime. Further, absolutely everyone who has used capsules is aware that the “line” among users and dealers is almost non-existent. Most people who use tablets also provide them to someone else in a single manner.
For those who survived the crack and powder cocaine sentencing disparities, the story of criminalization is all too familiar: mass incarceration and other suffering embedded inside communities that are hit the toughest with the aid of dependancy, disparities in offerings, a damaged safety internet. Consistently, those communities are black, brown, and experiencing poverty, like rural white communities in Connecticut. Yet, while confronted with a drug-associated difficulty like the overdose epidemic, the drug struggle has a funny manner of creating people.
Overlook the beyond every unmarried House member of Connecticut’s Black & Puerto Rican Caucus voted yes to increasing penalties for fentanyl. The bill was surpassed in the Senate with a vote of 33-3, whereas Sen. Winfield, D-New Haven, received the bill’s handiest no vote from the BPRC. In a state in which we have been hit tough by the overdose crisis, increasing criminalization of individuals who own capsules with fentanyl in them is not the solution. Fentanyl no longer comes from Connecticut. People dealing with addiction and mental fitness issues can have a bootleg drug and be unaware that it contains fentanyl.
Another piece of regulation that passed, An Act Concerning Opioid Use Disorder, might establish a statewide prescription drug monitoring application designed to lessen the number of overdoses associated with prescription opioids and other managed narcotics via digital tracking software. On the floor, this seems logical for the nation to take. However, the trouble with this regulation is that blended reviews support such applications’ efficacy. Even greater, there may be big research that links these legal.
Guidelines will increase deadly overdoses. These types of interventions have driven human beings far from prescribed substances to unpredictable illicit ones synthetic on the street. There was an alarming trend of continual pain sufferers whose situations are managed appropriately with opioid analgesics, who have been pressure-tapered or cut off from those medicines due to such applications. Limiting entry to opioids through restrictive laws to pressure many into the illicit market or, more tragically, to suicide.
The legislature additionally handed a bill to look at protocols and the feasibility of involuntary commitment of individuals who experienced an overdose. Evidence shows that coerced, involuntary treatment and related confinement are useless for long-term recovery and dangerous for overdose threats because of decreased tolerance. One look determined that folks who were involuntarily committed were more than two times as likely to enjoy a deadly overdose as folks who finished voluntary treatment.
The legislature must have taken an exclusive technique. Health-based regulations and interventions that we recognize work include low-threshold, instantly get right of entry to lifestyles-saving medicinal drugs like methadone and buprenorphine; significant distribution of naloxone and drug-testing resources like fentanyl test strips; syringe get entry to and harm discount programs; network organizing; and progressed get entry to
Healthcare. Though there have been some encouraging bills that surpassed via the legislature consultation, many of those related to opioid use represent a step backward for the nation. It is alarming that these payments are being touted as victories despite the overwhelming evidence demonstrating the harm they will cause. If we continue in this course, we will herald another new release of the failed drug struggle.
